Clinical Trial Update: Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase 1/Phase 2 clinical trial evaluating a ketogenic diet as an adjunct to high-dose methotrexate chemotherapy for primary central nervo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Primary Central Nervous System Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN